Literature DB >> 11722850

MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice.

M Wang1, C Orsini, D Casanova, J L Millán, A Mahfoudi, V Thuillier.   

Abstract

The improvement of gene therapy vectors would benefit from the availability of a reporter gene that can be used for long-term studies in immunocompetent laboratory animals. We describe the construction and characterization of a novel reporter gene, murine secreted embryonic alkaline phosphatase (MUSEAP). We demonstrate by gene transfer in skeletal muscle of immunocompetent mice that MUSEAP is efficiently secreted and detected in the bloodstream and that injection of an increasing dose of DNA leads to a dose-dependent increase of plasma MUSEAP activity. We also show that the expression of MUSEAP under the control of a constitutive promoter is stable for 1 year and that the activity of MUSEAP in the bloodstream reflects the changes in the transcription rate of its gene. These properties make MUSEAP the only reporter gene that can be used for somatic gene transfer into immunocompetent mice in order to study the impact of gene transfer vectors of metabolic, developmental or environmental factors on long-term gene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722850     DOI: 10.1016/s0378-1119(01)00754-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  12 in total

1.  Fasting increases the in vivo gene delivery of AAV vectors.

Authors:  Gilles Moulay; Daniel Scherman; Antoine Kichler
Journal:  Clin Transl Sci       Date:  2010-12       Impact factor: 4.689

2.  MRI-based detection of alkaline phosphatase gene reporter activity using a porphyrin solubility switch.

Authors:  Gil G Westmeyer; Yelena Emer; Jutta Lintelmann; Alan Jasanoff
Journal:  Chem Biol       Date:  2014-03-06

3.  Progress toward a nonviral gene therapy protocol for the treatment of anemia.

Authors:  Magdolna G Sebestyén; Julia O Hegge; Mark A Noble; David L Lewis; Hans Herweijer; Jon A Wolff
Journal:  Hum Gene Ther       Date:  2007-03       Impact factor: 5.695

Review 4.  Secreted blood reporters: insights and applications.

Authors:  Bakhos A Tannous; Jian Teng
Journal:  Biotechnol Adv       Date:  2011-09-08       Impact factor: 14.227

5.  C-reactive protein (CRP) is essential for efficient systemic transduction of recombinant adeno-associated virus vector 1 (rAAV-1) and rAAV-6 in mice.

Authors:  Jerome Denard; Beatrice Marolleau; Christine Jenny; Tata Nageswara Rao; Hans Jörg Fehling; Thomas Voit; Fedor Svinartchouk
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

6.  Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker.

Authors:  John A Ronald; Hui-Yen Chuang; Anca Dragulescu-Andrasi; Sharon S Hori; Sanjiv S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

7.  Human galectin 3 binding protein interacts with recombinant adeno-associated virus type 6.

Authors:  Jerome Denard; Cyriaque Beley; Robert Kotin; René Lai-Kuen; Stéphane Blot; Hervé Leh; Aravind Asokan; R Jude Samulski; Philippe Moullier; Thomas Voit; Luis Garcia; Fedor Svinartchouk
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

8.  Synthesis and evaluation of amphiphilic poly(tetrahydrofuran-b-ethylene oxide) copolymers for DNA delivery into skeletal muscle.

Authors:  Catherine Pomel; Christian Leborgne; Hervé Cheradame; Daniel Scherman; Antoine Kichler; Philippe Guegan
Journal:  Pharm Res       Date:  2008-09-03       Impact factor: 4.200

9.  Polymers for improving the in vivo transduction efficiency of AAV2 vectors.

Authors:  Gilles Moulay; Sylvie Boutin; Carole Masurier; Daniel Scherman; Antoine Kichler
Journal:  PLoS One       Date:  2010-12-28       Impact factor: 3.240

10.  Transduction of skeletal muscles with common reporter genes can promote muscle fiber degeneration and inflammation.

Authors:  Catherine E Winbanks; Claudia Beyer; Hongwei Qian; Paul Gregorevic
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.